Neulasta FIRST STEP® Program Registration

Welcome to the Neulasta FIRST STEP™ Program. Please complete the online form below to register your card.

If you have any questions or problems using your card after registration, please call 1-888-65-STEP1 (1-888-657-8371) from 9 a.m. to 8 p.m. ET, Monday-Friday.


ENTER CARD INFORMATION:
Step 1 of 2

* Required Data

Enter the last 4 digits of the 16-digit MasterCard number that appears in the
middle of the card:
*
 
Please type in the 7 or 8 digit Card number that appears on the bottom left of
your card after the letters NL:
*
Enter your 4-digit year of birth for verification (YYYY):
Do you belong to any state or federally funded health care
program such as Medicare, Medicare Advantage, Medicaid or TRICARE?
Yes     No
Do you have healthcare insurance?
Yes     No
Do you live in, or get treated in, the state of Massachusetts?
Yes     No
   

Please verify that all the information is correct and press submit when complete.

Indication

Neulasta® (pegfilgrastim) is prescribed to reduce the risk of infection (initially marked by fever) in patients with some tumors receiving strong chemotherapy that decreases the number of infection-fighting white blood cells.

Important Safety Information

Do not take Neulasta® if you have had an allergic reaction to Neulasta® (pegfilgrastim) or to NEUPOGEN® (filgrastim). Tell your doctor if you have sickle cell disorder before using Neulasta®. Ruptured spleen (including fatal cases), a serious lung problem called acute respiratory distress syndrome (ARDS), serious allergic reactions, and sickle cell crises can occur. Call your doctor or seek emergency care right away if you have: pain in the left upper stomach area or left shoulder tip pain (symptoms of an enlarged or ruptured spleen); shortness of breath, trouble breathing, or a fast rate of breathing (symptoms of ARDS); shortness of breath, wheezing, dizziness, swelling around the mouth or eyes, fast pulse, sweating, and hives (symptoms of an allergic reaction); or if you have pain or difficulty breathing (symptoms of sickle cell crises). The most common side effect you may experience is aching in the bones and muscles.

If you have any questions about this information, be sure to discuss them with your doctor. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Neulasta® product information.

The Neulasta FIRST STEP® Program is issued by The Bancorp Bank pursuant to license by MasterCard International and this card may not be used everywhere Debit MasterCard is accepted.  No cash or ATM access.  MasterCard is a registered trademark of MasterCard International Incorporated.  The Bancorp Bank; Member FDIC.